Combination chemotherapy is considered to be one of the most effective treatments for
breast cancer by reducing the emergence of drug resistance. In this study, a novel drug …

An appropriate co-delivery system for chemotherapeutic agents and nucleic acid drugs will
provide a more efficacious approach for the treatment of breast cancer by reversing …

Objective: The MDR of metastatic breast cancer cells is accompanied by the overexpression
of P-gp transporter. This study has been focused to determine whether silencing the …

Chemotherapeutic drugs have a series of limitations in the conventional clinical treatments,
mainly including serious adverse effects and multidrug resistance (MDR). Herein, we …

With the extensive application of doxorubicin (DOX), DOX resistance has become one of the
main obstacles to the effective treatment of breast cancer. In this paper, DOX and resveratrol …

The development of multidrug resistance (MDR) has become an increasingly serious
problem in cancer therapy. The cell membrane overexpression of P-glycoprotein (P-gp) …

Drug resistance is a major challenge for the clinical application of chemotherapeutic drugs.
In this study, a nanoparticle system containing hyaluronic acid (HA) shell and poly (β-amino) …

A facile strategy to construct a multiple drug delivery platform to overcome multidrug
resistance (MDR) was developed. A nano-sized albumin based drug delivery system with …

The combination of a chemotherapeutic drug with a chemosensitizer has emerged as a
promising strategy for cancers showing multidrug resistance (MDR). Herein we describe the …

Breast cancer is the most common cancer in women worldwide, and the incidence and
mortality rates have been increasing. Chemotherapy remains the main treatment strategy for …